N-(5-Bromothiazol-2-yl) acetamide hydrobromide, 95.0%, 10g

(4R,4'R)-2,2'-(1-PHENYLPROPANE-2,2-DIYL)BIS(4-ISOPROPYL-4,5-DIHYDROOXAZOLE), 95%, 1g

Methyl 3-(4-Hydroxy-3-methoxyphenyl)propionate>98.0%(GC)5g

2,6-Di(2H-1,2,3-triazol-4-yl)pyridine>98.0%(HPLC)200mg

2-(4-Cyano-phenyl)-N-Boc-ethylamine, 95.0%, 250mg

Plan phase PLPHi 10x/0,25 objectif IOS corrigé à l'infini. Distance de travail 5,00 mm

6-Chloro-1h-pyrrolo[3,2-b]pyridine-3-carbaldehyde, 98+%, 250mg

1-Boc-4-(2-Methoxyethylamino)piperidine, 95.0%, 10g

5-CHLOROPYRROLO[2,1-F][1,2,4]TRIAZIN-4(3H)-ONE, 95.0%, 500mg

5-Bromo-3-chloro-2-propan-2-yloxypyridine, 97%, 250mg

7-Methyl-5-nitro-1h-indole, 98%, 100mg

Tert-butyl n-(2-hydroxy-4-methylphenyl)carbamate, 95%, 100mg

2,3-Dichlorophenylisocyanide, 1g